The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
PAAB Quarterly Forum Review - Q3/2025
Blogs
1
Posts
1
Posters
15
Views
1
Watching
-
Happy Almost Friday @Manufacturer and @Agency
Your PAAB Q3 Forum Review is now live!
Some of the things that you might want to check out:
- AI assisted submission process - Call for volunteers
- ARO expansion
- Client Messenger Service
- Creative Imagery Document Posted
- Coming soon: RWE formatting update, new service offerings, and more...
As always, thoughts and feedback are welcome below
.
Thank you
PAAB
